Electrical Stimulation to Accelerate Wound Healing
Primary Purpose
Diabetes, Diabetic Foot Ulcer, Peripheral Neuropathy
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Electrical Stimulation - Active
Electrical Stimulation - Sham
Sponsored by
About this trial
This is an interventional supportive care trial for Diabetes focused on measuring electrical stimulation, wound healing, skin perfusion, home based therapy, diabetic foot, Foot ulcer
Eligibility Criteria
Inclusion Criteria:
- Able to provide informed consent
- 18-85 years old
- Clinically confirmed diabetes (ADA criteria)
- Clinically confirmed Peripheral Neuropathy
- One or more active non-infected ulcers
- Subject or responsible caregiver is willing and to maintain the required offloading (as applicable the location of the ulcer) and applicable dressing changes and electrical stimulation application.
Exclusion Criteria:
- Subject has a demand-type cardiac pacemaker, implanted defibrillator or other implanted electronic device
- Is pregnant
- Is nursing or actively lactating
- Has Renal Disease
- Active wound infection
- Active Charcot foot
- Non-ambulatory (unable to walk 40 feet with or without assistive device)
- Bilateral AK/BK amputation
- Active drug/alcohol abuse
- Dementia or impaired cognitive function
- Excessive lymphedema
- Osteomyelitis and/or gangrene
- Unable to comply with research appointments (e.g. long travel) Wide spread malignancy or systemically imumno-compromising disease
- Subject has a history of or any intercurrent illnesses or conditions that would compromise the safety of the subject according to judgement of a qualified wound specialist.
Sites / Locations
- Baylor College of Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
Electrical Stimulation - Active
Electrical Stimulation - Sham
Arm Description
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Outcomes
Primary Outcome Measures
Change in Skin Perfusion in Response to Electrical Stimulation Therapy
Lower-extremity skin perfusion will be assessed using a skin perfusion pressure device (PADIQ Sensilase). This device emerges pressure with a cuff placed around the calf muscle that has internal sensors. Then, the cuff is slowly released letting circulation to re-enter which is detected by the sensors.
Change in Wound Size in Response to Electrical Stimulation Therapy
Wound size will be assessed with a Sillouette Star 3D Camera that detects width, length, and depth of wounds that automatically gives you a cm2 area.
Secondary Outcome Measures
Change in Plantar Sensation in Response to Electrical Stimulation
change in plantar sensation will be assessed with a vibration pressure threshold device placed on the heel.
Change From Baseline to 60 Minutes in Tissue Oxygen Saturation in Response to Electrical Stimulation
Plantar tissue oxygen saturation will be assessed with Near infrared Spectroscopy device (KENT Imaging) at 60 minutes from baseline.
Change in Tissue Oxygen Saturation in Response to Electrical Stimulation
Plantar tissue oxygen saturation will be assessed with Near infrared Spectroscopy device (KENT Imaging)
Full Information
NCT ID
NCT03821675
First Posted
January 24, 2019
Last Updated
April 13, 2022
Sponsor
Baylor College of Medicine
Collaborators
Avazzia, Inc
1. Study Identification
Unique Protocol Identification Number
NCT03821675
Brief Title
Electrical Stimulation to Accelerate Wound Healing
Official Title
Electrical Stimulation as an Adjunctive Therapy to Accelerate Wound Healing in People With Diabetic Foot Ulcers - A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
February 28, 2019 (Actual)
Primary Completion Date
March 15, 2020 (Actual)
Study Completion Date
October 8, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Baylor College of Medicine
Collaborators
Avazzia, Inc
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
A clinical study at the Baylor College of Medicine, Division of Vascular Surgery and Endovascular Therapy, is being proposed to test the efficacy of a novel electrical stimulation platform named the Tennant Biomodulator designed by AVAZZIA to accelerate wound healing, relieve pain and improve mobility in patients with diabetic foot ulcers.
Detailed Description
Electrical stimulation may offer a unique treatment option to heal complicated and recalcitrant wounds, improve flap and graft survival, and even reduce the likelihood of ulceration. Electrical stimulation has been suggested to reduce infection, improve cellular immunity, increase perfusion, relieve pain, improve plantar sensation, and accelerate wound healing.
Electrical stimulation could have positive effect on not only increasing skin perfusion in patients with diabetes but also could improve mobility and balance via enhancing plantar sensation as demonstrated in our recent study. Thus, plantar stimulation not only may be beneficial to accelerate wound healing in diabetic foot ulcer (DFU) patients but also may assist to improve mobility and reduce the likelihood of recurrence of ulcers.
This study is proposed to examine the effectiveness of an innovative portable electrical stimulation platform (Tennant Biomodulator by AVAZZIA) to accelerate wound healing in DFU patients. It is hypothesized that 1) electrical stimulation will have an immediate effect on increasing skin perfusion (immediate benefit) and 2) daily use of the Tennant Biomodulator for 4 consecutive weeks is effective to speed up wound healing, increase skin perfusion, reduce pain, and improve balance and mobility in DFU patients (long term benefit)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes, Diabetic Foot Ulcer, Peripheral Neuropathy, Peripheral Arterial Disease
Keywords
electrical stimulation, wound healing, skin perfusion, home based therapy, diabetic foot, Foot ulcer
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Masking Description
Devices may be active or sham.
Allocation
Randomized
Enrollment
38 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Electrical Stimulation - Active
Arm Type
Active Comparator
Arm Description
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Arm Title
Electrical Stimulation - Sham
Arm Type
Sham Comparator
Arm Description
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Intervention Type
Device
Intervention Name(s)
Electrical Stimulation - Active
Intervention Description
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Intervention Type
Device
Intervention Name(s)
Electrical Stimulation - Sham
Intervention Description
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Primary Outcome Measure Information:
Title
Change in Skin Perfusion in Response to Electrical Stimulation Therapy
Description
Lower-extremity skin perfusion will be assessed using a skin perfusion pressure device (PADIQ Sensilase). This device emerges pressure with a cuff placed around the calf muscle that has internal sensors. Then, the cuff is slowly released letting circulation to re-enter which is detected by the sensors.
Time Frame
Change at 4 weeks from baseline.
Title
Change in Wound Size in Response to Electrical Stimulation Therapy
Description
Wound size will be assessed with a Sillouette Star 3D Camera that detects width, length, and depth of wounds that automatically gives you a cm2 area.
Time Frame
Change at 4 weeks from baseline
Secondary Outcome Measure Information:
Title
Change in Plantar Sensation in Response to Electrical Stimulation
Description
change in plantar sensation will be assessed with a vibration pressure threshold device placed on the heel.
Time Frame
Change at 4 weeks from baseline.
Title
Change From Baseline to 60 Minutes in Tissue Oxygen Saturation in Response to Electrical Stimulation
Description
Plantar tissue oxygen saturation will be assessed with Near infrared Spectroscopy device (KENT Imaging) at 60 minutes from baseline.
Time Frame
Change at 60 minutes from baseline.
Title
Change in Tissue Oxygen Saturation in Response to Electrical Stimulation
Description
Plantar tissue oxygen saturation will be assessed with Near infrared Spectroscopy device (KENT Imaging)
Time Frame
Change at 4 weeks from baseline.
Other Pre-specified Outcome Measures:
Title
Change From Baseline in Skin Perfusion in Response to Electrical Stimulation
Description
Lower-extremity skin perfusion will be assessed using a skin perfusion pressure device (PADIQ Sensilase). This device emerges pressure with a cuff placed around the calf muscle that has internal sensors. Then, the cuff is slowly released letting circulation to re-enter which is detected by the sensors.
Time Frame
an average of 60 minutes from baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Able to provide informed consent
18-85 years old
Clinically confirmed diabetes (ADA criteria)
Clinically confirmed Peripheral Neuropathy
One or more active non-infected ulcers
Subject or responsible caregiver is willing and to maintain the required offloading (as applicable the location of the ulcer) and applicable dressing changes and electrical stimulation application.
Exclusion Criteria:
Subject has a demand-type cardiac pacemaker, implanted defibrillator or other implanted electronic device
Is pregnant
Is nursing or actively lactating
Has Renal Disease
Active wound infection
Active Charcot foot
Non-ambulatory (unable to walk 40 feet with or without assistive device)
Bilateral AK/BK amputation
Active drug/alcohol abuse
Dementia or impaired cognitive function
Excessive lymphedema
Osteomyelitis and/or gangrene
Unable to comply with research appointments (e.g. long travel) Wide spread malignancy or systemically imumno-compromising disease
Subject has a history of or any intercurrent illnesses or conditions that would compromise the safety of the subject according to judgement of a qualified wound specialist.
Facility Information:
Facility Name
Baylor College of Medicine
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Electrical Stimulation to Accelerate Wound Healing
We'll reach out to this number within 24 hrs